SEP 22, 2016 5:10 AM PDT

Autism, Zoloft and Fragile X: New Information

 
With autism statistics at 1 in 68 children, the search for information on the causes and possible treatments is a priority for many neuroscientists. While there is no known cause of autism, it occurs in approximately 60% of children who have Fragile X syndrome so researchers are looking at ways the two disorders are connected. Fragile X is a genetic disorder that causes certain facial features like a large forehead and ears as well as intellectual disabilities, social anxiety and self-stimulating behavior like hand flapping. It occurs as a result of the expansion of the CGG trinucleotide repeat affecting the Fragile X mental retardation 1 (FMR1) gene on the X chromosome, resulting in a failure to express the fragile X mental retardation protein (FMRP), which is required for normal neural development.
 New information on Fragile X and autism
There are no treatments available for Fragile X itself, nor are there medications for most autism spectrum disorders however some children who have ADHD or anxiety along with these conditions do take medications for focus and/or stress relief. New research into how it relates to autism might offer another avenue for treatment however.
 
A study by researchers with the UC Davis MIND Institute has found that treatment with the anti-depressant drug sertraline (brand name Zoloft) may provide small but important improvements in intellectual ability and social participation in children with fragile X syndrome, but only at very young ages. The study is published online in the Journal of Developmental & Behavioral Pediatrics and is the first clinical trial to look at low doses of Zoloft for the learning and emotional issues children with the genetic disorder suffer from.  The researchers noted that language acquisition also improved in the children who took Zoloft.
 
In a press release from UC Davis Randi Hagerman, senior author and medical director of the UC Davis MIND Institute stated, “These are important outcomes that warrant further studies of sertraline in fragile X syndrome and in autism spectrum disorder. All of the families that completed the study wanted to continue their children on sertraline.”
 
Since Zoloft is a selective serotonin reuptake inhibitor (SSRI) and serotonin levels are low during early development, when synapse formation is most rapid there is a window in the first five years of a child’s life where boosting serotonin levels could improve development. This very crucial period of time in a child’s life could be the best time for treatments that involve SSRIs. Previous research in mouse models also showed that SSRIs stimulate a substance in the brain called brain-derived neurotrophic factor (BDNF) which is necessary for proper synaptic growth. Hagerman believes there could be a link between SSRIs and this development in children with Fragile X.
 
“Given the lack of maturation of synapses in fragile X syndrome, along with BDNF’s role in synaptic maturation, plasticity and neurogenesis, SSRIs are of particular interest for the treatment of fragile X syndrome,” Hagerman said.
 
The research involved 52 children between the ages of 2 and 5 who were monitored for cognitive development and social skills for a period of 3.5 years. Half of the children were given Zoloft and half a placebo. The children who received the medication showed better progress in areas of cognition and social functioning as well as language development. In the video below Dr. Hagerman explains more about the study and what it might mean for children affected by Fragile X.

Sources: UC DavisJournal of Developmental Behavioral Pediatrics, National Fragile X Foundation
 
About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
JUL 04, 2021
Genetics & Genomics
New Insights Into the Mechanisms of Rett Syndrome
JUL 04, 2021
New Insights Into the Mechanisms of Rett Syndrome
Rett syndrome is a neurological disorder that mostly affects girls; affected individuals develop normally until they're ...
JUL 06, 2021
Cell & Molecular Biology
Can Some Brain Plasticity Be Restored with Ketamine or Light?
JUL 06, 2021
Can Some Brain Plasticity Be Restored with Ketamine or Light?
The perineuronal net is known to play a crucial role in memory. This structure surrounds certain neurons, encasing their ...
JUL 15, 2021
Cannabis Sciences
Cannabis Terpenes Provide Pain Relief in Mice
JUL 15, 2021
Cannabis Terpenes Provide Pain Relief in Mice
Cannabis terpenes, the part of cannabis plants responsible for its smell and taste, may be able to relieve pain both by ...
AUG 17, 2021
Drug Discovery & Development
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
AUG 17, 2021
Severe daytime sleepiness? A new drug can help: FDA approves Xywav to treat idiopathic hypersomnia.
     Being tired throughout the day is a common feeling for most individuals. In fact, 1 out of every 5 A ...
SEP 05, 2021
Microbiology
Gut Bacteria May Influence Infant Brain Development
SEP 05, 2021
Gut Bacteria May Influence Infant Brain Development
Our health is closely connected to the community of microbes we carry in our gut. For example, these microbes have a pow ...
SEP 15, 2021
Neuroscience
Motor Cortex Involved in Vocabulary Learning
SEP 15, 2021
Motor Cortex Involved in Vocabulary Learning
The motor cortex, the part of the brain involved in the planning, control, and execution of voluntary movements, may pla ...
Loading Comments...